Myeloprotection by Cytidine Deaminase Gene Transfer in Antileukemic Therapy
Gene transfer of drug resistance (CTX-R) genes can be used to protect the hematopoietic system from the toxicity of anticancer chemotherapy and this concept recently has been proven by overexpression of a mutant O6-methylguaninemethyltransferase in the hematopoietic system of glioblastoma patients...
Main Authors: | Nico Lachmann, Sebastian Brennig, Ruhi Phaltane, Michael Flasshove, Dagmar Dilloo, Thomas Moritz |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2013-03-01
|
Series: | Neoplasia: An International Journal for Oncology Research |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1476558613800541 |
Similar Items
-
Synthesis of a bifunctional cytidine derivative and its conjugation to RNA for in vitro selection of a cytidine deaminase ribozyme
by: Nico Rublack, et al.
Published: (2014-08-01) -
Characteristics and efficacy of cytosine and cytidine deaminase
by: Qusay Chalabi, et al.
Published: (2007-01-01) -
Deaminase-independent inhibition of parvoviruses by the APOBEC3A cytidine deaminase.
by: Iñigo Narvaiza, et al.
Published: (2009-05-01) -
Biological function of activation-induced cytidine deaminase (AID)
by: Ritu Kumar, et al.
Published: (2014-10-01) -
Intrinsic immunity against retrotransposons by APOBEC cytidine deaminases
by: Atsushi eKoito, et al.
Published: (2013-02-01)